J&J receives FDA warning letter for unapproved med device products

CNN Money reports that the FDA has set Johnson and Johnson a warning letter for selling joint products have have yet to be approved. By selling these products, they are violating the Federal Food, Drug and Cosmetic Act. Upon receiving information from DePuy, the Johnson and Johnson subunit, it will then test products for market approval.

This blog is co-posted with The Drug Delivery Blog.

Share this article with your social network, just click below to share now!

Share |